NASUS PHARMA LTD

Q2 2026 13F Holders

Symbol
NSRX
CUSIP
M7071P109
Type
Equity
Class
ORD SHS
Num filings
10
Total reported value, excl. options
$7.53 M
Manager Report Date Value ($000) Shares Option Type